Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	-	2.29	17.72	17.36
Cash & Short-Term Investments	-	-	2.29	17.72	17.36
Cash Growth	-	-	-87.09%	2.12%	-15.82%
Other Current Assets	0.26	0.49	1.29	0.71	0.38
Total Current Assets	4.94	2.73	3.58	18.43	17.74
Net Property, Plant & Equipment	0.16	0.31	0.51	0.74	0.47
Other Intangible Assets	-	0.04	0.21	0.38	6.92
Goodwill	-	-	-	-	1.59
Total Assets	5.1	3.08	4.3	19.55	26.72
Accounts Payable	0.58	0.52	1.22	0.46	0.68
Accrued Expenses	0.24	0.74	1.08	1.71	1.29
Current Portion of Leases	-	-	-	0.06	0.11
Other Current Liabilities	0.1	0.23	0.05	1.76	0.65
Total Current Liabilities	0.92	1.49	2.34	4	2.74
Long-Term Leases	-	-	-	-	0.07
Other Long-Term Liabilities	-	-	-	-	1.61
Total Long-Term Liabilities	-	-	-	-	1.68
Total Liabilities	0.92	1.49	2.34	4	4.41
Common Stock	0.01	0	0	0.02	0.01
Additional Paid-in Capital	-	-	99.02	94.4	83.07
Accumulated Other Comprehensive Income	-	-	-0.57	-0.54	-0.03
Retained Earnings	-114.85	-106.07	-96.5	-79.21	-60.74
Total Common Shareholders' Equity	-114.84	-106.07	1.96	14.67	22.31
Minority Interest	-	-	-	0.89	-
Shareholders' Equity	-114.84	-106.07	1.96	15.56	22.31
Total Liabilities & Equity	5.1	3.08	4.3	19.55	26.72
Total Debt	0	0	0	0.06	0.18
Net Cash (Debt)	-0	-0	2.29	17.66	17.18
Net Cash Growth	-	-	-87.04%	2.80%	-16.07%
Net Cash Per Share	-	-	190.76	2198.33	6546.81
Book Value	-114.84	-106.07	1.96	14.67	22.31
Book Value Per Share	-343.08	-2531.11	163.11	1826.37	8500.31
Tangible Book Value	-114.84	-106.12	1.75	14.29	13.79
Tangible Book Value Per Share	-343.08	-2532.12	145.52	1779.11	5256.73

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q